NovaCentrix Acquires Copper Ink Formulations in Asset Sale from Intrinsiq Materials

NovaCentrix, Austin, TX, announced it has exclusively acquired the technical and business-related intellectual property (IP) of Intrinsiq Materials in an asset sale by Intrinsiq Materials investors.
 
The IP originating from both the original Intrinsiq Materials location in the UK as well as the location in Rochester, NY is included. Additionally, industry veteran chemist and copper inks expert Dr. Michael Carmody, previously serving as Intrinsiq Materials’ chief scientist and based at the Rochester location, has joined the NovaCentrix team.
 
“We are committed to supporting the existing customers of the copper ink technology previously offered by Intrinsiq Materials,” said Stan Farnsworth, NovaCentrix chief marketing officer. “Additionally, this proven copper-based inks technology provides a powerful expanded set of capabilities for our customers. With continued refinement this copper ink technology will increasingly meet opportunities in emerging applications as well as existing traditional electronics markets.”
 
Dr. Carmody will continue to lead the development of the copper ink technologies and applications. “This new chapter provides a new opportunity to push this work forward. I’m excited by the welcome I’ve received by the team here at NovaCentrix,” he said.
 
Advances in the copper conductive ink capabilities will be unveiled at upcoming industry events throughout 2019, and will be shared through the NovaCentrix website. As new products are released, they will be made available on the NovaCentrix webstore.

Source: NovaCentrix